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ABSTRACT 
Basal 24 hour urina r y k a l l i k r e i n e x c r e t i o n of 20 
p a t i e n t s with uncomplicated e s s e n t i a l hypertension d i d 
not d i f f e r s i g n i f i c a n t l y from that of 18 normotensive 
age-matched c o n t r o l s u b j e c t s . 4 of the 20 h y p e r t e n s i -
ve p a t i e n t s , however, had low k a l l i k r e i n e x c r e t i o n . 
Furosemide (40 mg i.v.) caused an increase of u r i n a r y 
k a l l i k r e i n e xcretion i n the normotensive subjects and 
i n most of the p a t i e n t s with e s s e n t i a l hypertension. 
The s t i m u l a t i n g e f f e c t of furosemide was l e s s pronoun-
ced or even absent i n 7 hypertensives. No c i r c a d i a n 
rhythm of u r i n a r y k a l l i k r e i n e x c r e t i o n was observed. 
There were weak c o r r e l a t i o n s between 24 hour k a l l i k r e i n 
e x c r e t i o n and u r i n a r y volume (r=0.59; p< 0.05), and 
potassium e x c r e t i o n (r=0.51; p<0.05) i n the normoten-
s i v e s . In the hypertensives c o r r e l a t i o n s were found 
between 24 hour k a l l i k r e i n e x c r e t i o n and potassium ex-
c r e t i o n (r=0.51; p<0.05), aldosterone e x c r e t i o n (r= 
0.57; p < 0.01), and c r e a t i n i n e clearance (r=0.59? 
p < 0.01) . Our f i n d i n g s do not support the concept that 
the r e n a l k a l l i k r e i n - k i n i n system might play a primary 
r o l e i n the pathogenesis of e s s e n t i a l hypertension. 
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INTRODUCTION 
K a l l i k r e i n detected i n the urine i s probably f o r -
med i n and secreted by the kidney (13) . A possible ro-
le of the i n t r a r e n a l k a l l i k r e i n - k i n i n system i n renal 
handling of water and e l e c t r o l y t e s has been discussed 
(1, 2, 14). There seems to be a close i n t e r r e l a t i o n 
between the k a l l i k r e i n - k i n i n system and the r e n i n -
angiotensin-aldosterone system as well as the renal 
prostaglandins (2). However, the p h y s i o l o g i c a l r o l e of 
the renal k a l l i k r e i n - k i n i n system i s s t i l l f ar from 
being c l e a r . 
A subnormal urinary k a l l i k r e i n (U.Kall.) excre-
t i o n i n patients with e s s e n t i a l hypertension (EH) had 
already been described more than 40 years ago (4, 20). 
The i n t e r e s t i n t h i s subject was revived by the studies 
of Margolius et a l . (12) who reconfirmed the older 
findings and proposed a possible role of the renal 
k a l l i k r e i n - k i n i n system i n the pathogenesis of hyper-
tension. 
The aim of t h i s study was to examine the possible 
i n t e r r e l a t i o n between the U.Kall, excretion and the 
urinary water and e l e c t r o l y t e excretion, as w e l l as 
with the renin-angiotensin-aldosterone system i n nor-
motensive subjects (NS) and i n patients with EH. 
PATIENTS AND METHODS 
A t o t a l of 18 male NS and 20 male patients with 
mild (WHO grade I, n=13) or moderate EH (WHO grade I I , 
n=7) between 19 and 50 years of age were included i n 
the study. The mean age of the NS was 33+2.1 (SEM) 
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and of the p a t i e n t s with EH 35 + 2.1 years. Subjects 
were considered to be hypertensive when d i a s t o l i c blood 
pressure was above 90 mm Hg at measurements on three 
d i f f e r e n t days. Secondary causes of hypertension had 
been excluded i n a l l cases by appropriate methods. 
Average blood pressure i n the NS was 117 + 1.9/75 
+1.7 ( s y s t o l i c / d i a s t o l i c ) mm Hg and i n the p a t i e n t s 
with EH 161 + 5.0/106 + 2.1 mm Hg. Antihypertensive 
treatment had been withdrawn f o r at l e a s t two weeks, 
d i u r e t i c agents had been withdrawn f o r at l e a s t four 
weeks p r i o r to the study. 10 p a t i e n t s with EH had not 
been t r e a t e d with antihypertensive drugs or d i u r e t i c s 
before. 
Studies were performed under outpatient conditions 
without d i e t a r y r e s t r i c t i o n s . However, n i c o t i n e , a l c o -
h o l , and c a f f e i n e were not allowed 12 hours before and 
during the s t u d i e s . Urine was c o l l e c t e d f o r 24 hours 
i n three 8 hour periods (period I: 7 a.m. - 3 p.m.; 
period I I : 3 p.m. - 11 p.m.; period I I I : 11 p.m. -
7 a.m.). In 3 NS and 5 p a t i e n t s with EH urine was c o l -
l e c t e d i n a s i n g l e 24 hour period only. On the f o l l o -
wing morning, a f t e r a 30 min r e s t i n g p e r i od, blood sam-
ples were taken from the f a s t i n g i n d i v i d u a l s f o r e s t i -
mation of plasma renin a c t i v i t y (PRA) and c r e a t i n i n e . 
Thereafter, 40 mg of furosemide (Lasix ) were given 
intravenously and urine was c o l l e c t e d f o r another 30 
min p e r i o d . At the end of the c o l l e c t i o n period blood 
was taken again f o r estimation of PRA. 
In the urine samples of each c o l l e c t i o n p e r i o d 
k a l l i k r e i n , c r e a t i n i n e , sodium, potassium, and aldo-
sterone were measured. U . K a l l , was estimated by four 
d i f f e r e n t methods: 
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1. The amidolytic a c t i v i t y of Ü.Kall, was estimated 
using the synthetic chromogenic substrate D - v a l y l -
L - l e u c y l - L - a r g i n i n e - p - n i t r o a n i l i d e (S 2266; Kabi) 
as suggested by Kabi company (Stockholm). The ami-
d o l y t i c a c t i v i t y of U.Kall, measured by t h i s method 
i s equal to the f r a c t i o n of the t o t a l amidolytic ac-
t i v i t y i n urine which i s i n h i b i t e d by addition of 
aprotini n ( T r a s y l o l ). To make sure t^at k a l l i k r e i n 
a c t i v i t y was t o t a l l y i n h i b i t e d , 25 U/inl of the k a l l i -
krein i n h i b i t o r a p r o t i n i n were added to the sample's 
blank, which i s 2.5 times the amount suggested by 
Kabi. The amidolytic a c t i v i t y of U.Kall, was e s t i -
mated in non-dialyzed as well as i n dialyzed urine 
samples. 
2. The e s t e r o l y t i c a c t i v i t y of U.Kall, was measured 
using the synthetic substrate acetyl-L-phenylalany1 -
L-arginine-ethylester (APAE) as proposed by Fied-
l e r et a l . (5). This method allows measurements of 
U.Kall, i n dialyzed urine only. 
Values of U.Kall, a c t i v i t y of assay 1 and 2 are ex-
pressed i n units of substrate s p l i t t i n g a c t i v i t y (U/l= 
limole/min/l) . 
3. Bioassay: The blood pressure lowering e f f e c t of 
U.Kall, was tested i n mongrel dogs (weight: 8-10 kg) 
anesthetized with sodium pentobarbitone (Nembutal1* 
40 mg/kg) following intravenous i n j e c t i o n s of d i a -
lyzed urines. Blood pressure was measured i n t r a a r -
t e r i a l l y i n the hindlimb. 
4. U.Kall was also estimated by a d i r e c t radioimmuno-
assay (RIA) (10) i n non-dialyzed and i n dialyzed 
urines. 
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FIGURE 1 
C o r r e l a t i o n between the amidolytic (S 2266) and the 
e s t e r o l y t i c (APAE) a c t i v i t y of urinary k a l l i k r e i n 
(U.Kall.) i n urines of normotensive and hypertensive 
su b j e c t s . For further explanation see t e x t . 
Standard curves f o r bioassay and d i r e c t RIA were ob-
tained using a p u r i f i e d human urinary k a l l i k r e i n pre-
p a r a t i o n (7). The U . K a l l , values of these assays are 
expressed i n ng/ml. 
A l i q u o t s of the urine samples were d i a l y z e d 
against d i s t i l l e d water at + 4°C f o r 24 hours and 
non-dialyzed samples (assay 1 und 4) were stored at 
+ 4°C f o r 24 hours. Thereafter samples were e i t h e r ana-
lyzed immediately or frozen at -20°C. 
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Measurements of the amidolytic and the e s t e r o l y -
t i c a c t i v i t y of the urine samples were performed with-
i n 48 hours a f t e r urine c o l l e c t i o n had been completed. 
Preliminary experiments i n our laboratory had shown 
that i n non-dialyzed urines the amidolytic a c t i v i t y 
may decrease by as much as 75 % a f t e r only 4 weeks of 
storage at -20°C. The bioassay was performed within 
one week, and the radioimmunological determinations 
were done within two months. 
Sodium, potassium, and creatinine were measured 
by standard methods. Urinary aldosterone was determi-
ned by RIA. PRA was estimated as previously described 
(3) . 
S t a t i s t i c a l evaluations of the r e s u l t s were per-
formed by Student's t - t e s t , analysis of variance and 
l i n e a r regression analysis. Data are given as means + 
SEM. 
RESULTS 
Comparison of D i f f e r e n t Methods for Urinary K a l l i k r e i n 
Determination : Comparing the d i f f e r e n t methods used 
for estimation of U.Kall, in NS and patients with EH 
the following c o r r e l a t i o n s were obtained. 
1. S 2266 (y) vs. APAE (x) i n dialyzed urines (n=123): 
y = 0.0168 x + 0.0051; r = 0.98 p < 0.001 (Fig.1) 
2. Bioassay (y) vs. S 2266 (x) i n dialyzed urines (n=71 ) : 
y = 0.44 x + 0.76; r = 0.80 p < 0.01 
3. RIA (y) vs. S 2266 (x) i n non-dialyzed urines (n=22) : 
y = 1.18 x - 2.25; r = 0.95 p < 0.001 
4. RIA (y) vs. S 2266 (x) i n dialyzed urines (n=22): 
y = 0.88 x - 1.14; r = 0.91 p < 0.001 
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5. RIA (y) in non-dialyzed vs. RIA (x) i n dialyzed 
urines (n=22): 
y = 0.96 x + 3.17; r = 0.95 p <0.001 
The U.Kall, data presented below as well as i n 
F i g . 2-4 and i n Table 1 have been obtained by using 
S 2266 as substrate. 
Basal Urinray K a l l i k r e i n Excretion (Fig.2): 24 hour 
k a l l i k r e i n excretion as measured by the amidolytic ac-
t i v i t y of U.Kall, i n the NS and patients with EH i s de-
monstrated i n Fig.2. No s i g n i f i c a n t differences i n the 
U.Kall, excretion were found between the two groups. 
Individual values varied considerably i n both groups. 
In the NS the range of U.Kall, i n non-dialyzed urines 
was from 347 to 1568 mU/24 h; in the patients with EH 
U.Kall, ranged from 145 to 2089 mU/24 h. D i a l y s i s of 
urines led to a consistent increment of U.Kall, i n a l l 
subjects with one exception i n the NS. 
Mean increase of U.Kall, was 20 % i n the NS, and 
28 % i n the patients with EH. U.Kall, excretion of 4 
patients with EH was lower than that found i n the NS. 
2 of these 4 patients had established hypertension 
(WHO grade I I ) . 
Urinary K a l l i k r e i n Excretion and Plasma Renin A c t i v i t y 
following Furosemide (Fig. 3, Table 1); Furosemide 
caused a marked increase of U.Kall, excretion i n the 
following 30 min i n both groups (NS: p < 0.001; EH: 
p < 0.01) compared to the mean basal excretion per 30 
min. The mean increase of U.Kall, excretion was s i m i l a r 
i n both groups (Table 1). In 7 patients with EH, how-
ever, a smaller increase or even a decrease of U.Kall, 
excretion was observed when compared to the NS. 3 of 
these 7 patients had established EH (WHO grade I I ) . 
TABLE 1 o o 
U.Kall. (S 2266) PRA Volume Sodium Potassium CCr Aldosterone 
rail/period ng/ml/h ml/period meq/period meq/period ml/min/1 73m
2
 ug/period 
non-dialysed dialysed 
period I NS 282+ 37 350+ 34
### 
427+ 55 56+ 8 35.9+3.1 115+9 5.9+1.1 
7 a.m. - 3 p.m. EH 317* 55 401+ 60*^ 466+ 42 66+ 6 31.5+2.0 120+9 6.2+0.7 
period II NS 283+ 32 321+ 32
# 
558+ 74 75+ 6 29.0+3.6 107+6 3.6+0.5 
3 p.m. - 11 p.m. EH 271+ 44 329+ 50~* 522+ 68 80+ 9 29.4+3.1 119+7 5.3+0.6 
period III NS 257+ 38 315+ 39~ 431+ 66 52+ 6 14.8+1.8 99+4 3.0+0.5 
11 p.m. - 7 a.m. EH 264+ 38 347+ 44
##
* 433+ 55 65+ 9 15.3+1.2 102+5 3.6+0.5 
period I+II+III NS 822+ 97 986+ 9 6 — 1416+156 184+16 79.6+6.8 107+5 12.5+2.0 
7 a.m. - 7 a.m. EH 850*129 1072+146
IMMI 
1421+138 211+20 76.2+4.5 113+5 15.1+1.5 
control NS 17.6+1.8 2.3+0.2 30+ 3 3.7+0.3 1.6+0.1 105+4 
30 min EH 22.7+2.6 2.4+0.4 30+ 3 4.4+0.4 1.6+0.1 117+5 
furosemide NS 37.2+3.7 6.3*0.7 523+18 67.0+2.3 8.7+0.4 106+9 
30 min EH 36.6+4.0 5.6+1.2 487+21 63.2+2.8 7.8+0.3 101+5 
•p<0.05;
 #
*p<0.01;
 ###
p<0.001 
Urinary kallikrein, volume, sodium, potassium, aldosterone excretion, creatinine clearance, and plasma renin activity 
in normotensive subjects (NS) and patients with essential hypertension (EH) under basal conditions (NS: n = 15, except 
aldosterone excretion: n * 14; EH: n = 15) and after furosemide (40 mq i.v.)(NS: n * 15; EH: n = 20). 
U.Kall.* urimry kallikrein; PRA = plasma renin activity; C
r^
 = creatinine clearance; control: mean per 30 nun of 
basal 24 h excretion. 
Mean values • SEM. 
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FIGURE 2 
24 hour urinary k a l l i k r e i n (U.Kall.) excretion i n nor-
motensive and hypertensive subjects. The amidolytic ac-
t i v i t y of U.Kall, was measured using the synthetic sub-
strate S 2266. Note the consistent increase (except one 
in the normotensive group) of U.Kall, following d i a l y -
s i s of urine samples. 
During recumbency 'and a f t e r furosemide stimulation 
mean values of PRA did not d i f f e r s i g n i f i c a n t l y i n both 
groups, whereas the percent r i s e of PRA was lower (p< 
0.05) i n the patients with EH compared to the NS. No 
c o r r e l a t i o n was found e i t h e r between absolute values 
or percent changes of PRA and U.Kall, excretion before 
and a f t e r furosemide administration. 
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FIGURE 3 
Plasma ren i n a c t i v i t y (PRA) and urina r y k a l l i k r e i n 
(U.Kall.) e x c r e t i o n (dialyzed urines; substrate S 2266) 
i n normotensive and hypertensive subjects under basal 
conditions and 30 min a f t e r furosemide (40 mg i.v.) 
adm i n i s t r a t i o n . 
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Urinary K a l l i k r e i n Excretion, Urine Volume, Sodium, Po-
tassium, Aldosterone Excretion and Creatinine Clearan-
ce i n Periods I, I I , III and following Furosemide (Fig.4, 
Table 1): There were no s i g n i f i c a n t d i fferences of U. 
K a i l , excretion, urine volume, sodium, potassium, a l -
dosterone excretion, and cr e a t i n i n e clearance between 
NS and patients with EH i n each period. Comparing the 
three periods only the potassium excretion (period I, 
II vs. I l l ; p < 0.05) and the aldosterone excretion 
(period I vs. I I I ; p < 0.05) proved to be d i f f e r e n t i n 
both groups as was shown by analysis of variance. 
Values of urine volume, sodium, potassium excre-
t i o n , and cre a t i n i n e clearance following the admini-
s t r a t i o n of furosemide were s i m i l a r i n both groups 
(Table 1). 
In the NS p o s i t i v e correlations were found between 
t o t a l U.Kall./24 h (non-dialyzed urines) and urine vo-
lume/24 h (r=0.59; p < 0.05), U.Kall./24 h (non-dialy-
zed urines) and potassium excretion/24 h (r=0.51; p< 
0.05); i n patients with EH between U.Kall./24 h (dia-
lyzed urines) and potassium excretion (r=0.51; p<0.05), 
U.Kall./24 h (dialyzed urines) and aldosterone excre-
tion/24 h (r=0.57; p < 0.01), U.Kall./24 h (dialyzed 
urines) and mean cre a t i n i n e clearance/24 h (r=0.59; 
p < 0.01). However, no c o r r e l a t i o n s could be revealed 
between U.Kall, and urinary excretion of the parame-
ters mentioned above i n periods I, II or I I I and f o l l o -
wing furosemide administration i n e i t h e r group. 
DISCUSSION 
Comparison of the d i f f e r e n t k a l l i k r e i n assays de-
monstrates that the synthetic substrates used are ap-
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FIGURE 4 
Urinary k a l l i k r e i n (U.Kall.), (non-dialyzed urines; 
substrate S 2266) , urine volume (UV) , sodium (UN^V) , 
aldosterone, potassium excretion (U V) , and creatinine 
clearance (Cc r) i n period I, I I , ana III in normotensi-
ve and hypertensive subjects. For further explanation 
see text. (Aldosterone excretion i n normotensives: n=14) 
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p r o p r i a t e f o r the estimation of urinary k a l l i k r e i n . 
D i a l y s i s of urine samples r e s u l t e d i n an increase of the 
amidolytic a c t i v i t y . However, urinar y k a l l i k r e i n d i d 
not d i f f e r when the d i r e c t RIA was ap p l i e d . The i n c r e a -
se of k a l l i k r e i n a c t i v i t y f o l l o w i n g d i a l y s i s could be 
due to the removal of i n h i b i t o r y substances which might 
be present i n the untreated u r i n e . I t seems p o s s i b l e 
that a s p e c i f i c k a l l i k r e i n i n h i b i t o r as found i n r e n a l 
tubules i n r a t s (6) i s excreted into the urine and par-
t i a l l y removed by d i a l y s i s . 
In the present study we d i d not f i n d a d i f f e r e n c e 
i n the mean basal k a l l i k r e i n e x c r e t i o n between the pa-
t i e n t s with uncomplicated EH and age-matched normoten-
siv e c o n t r o l s u b j e c t s . Only 4 out of 20 pa t i e n t s with 
EH showed low k a l l i k r e i n e x c r e t i o n . A normal k a l l i k r e i n 
e x c r e t i o n has a l s o been reported by Lawton and F i t z (8) 
who compared younger male pa t i e n t s with mild EH with 
age-matched c o n t r o l subjects. Other authors reported 
upon a normal k a l l i k r e i n e x c r e t i o n i n l a b i l e EH, and a 
decreased k a l l i k r e i n e x c r e t i o n i n e s t a b l i s h e d EH (15, 
18). The l a t t e r f i n d i n g s are compatible with the assump-
t i o n that subnormal k a l l i k r e i n e x c r e t i o n could be se-
condary to the hypertensive process. This i n t e r p r e t a -
t i o n i s supported by data of Holland et a l . (personal 
communication) who found k a l l i k r e i n e x c r e t i o n to be nor-
mal i n p a t i e n t s with EH and normal r e n a l function ( crea-
t i n i n e clearance > 80 ml/min), but decreased i n pa t i e n t s 
with EH and reduced r e n a l f u n c t i o n ( c r e a t i n i n e c l e a r a n -
ce 40 - 80 ml/min) . The p o s i t i v e correlation between k a l l i -
krein excretion and creatinine clearance ve observed in the patients 
with EH would be con s i s t e n t with Holland's data. 
Furosemide i s known to stimulate u r i n a r y k a l l i -
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k r e i n e x c r e t i o n . In p a t i e n t s with EH, however, a redu-
ced s t i m u l a t i n g e f f e c t of furosemide on u r i n a r y k a l l i -
k r e i n e x c r e t i o n has been reported (17, 19). We obser-
ved a diminished s t i m u l a t i o n of k a l l i k r e i n e x c r e t i o n 
only i n a minority of p a t i e n t s with EH. As demonstra-
ted i n r a t s , increments of u r i n a r y k a l l i k r e i n e x c r e t i o n 
f o l l o w i n g furosemide adm i n i s t r a t i o n are due to an i n -
creased synthesis rate i n the kidney (16). Therefore, 
our f i n d i n g s could i n d i c a t e a reduced synthesis of 
k a l l i k r e i n i n the kidneys f o l l o w i n g furosemide stimu-
l a t i o n i n a proportion of p a t i e n t s with EH. 
Levy et a l . (9) reported on a day-night rhythm of 
k a l l i k r e i n e x c r e t i o n i n white p a t i e n t s with EH, but 
not i n black p a t i e n t s with EH or i n normal c o n t r o l sub-
j e c t s . In t h i s study no c i r c a d i a n rhythm of ur i n a r y 
k a l l i k r e i n e x c r e t i o n was observed. There was, however, 
a s i m i l a r c i r c a d i a n rhythm of potassium and a l d o s t e r o -
ne e x c r e t i o n i n both groups ( F i g . 4). Neither between 
k a l l i k r e i n and potassium e x c r e t i o n nor between k a l l i -
k r e i n and aldosterone e x c r e t i o n a c o r r e l a t i o n could 
be demonstrated i n any 8 hour per i o d . There was, how-
ever, a p o s i t i v e c o r r e l a t i o n between the k a l l i k r e i n ex-
cretion/24 h and the potassium excretion/24 h (in NS 
and EH), and a l s o between the k a l l i k r e i n e x c r e t i o n / 
24 h and the aldosterone excretion/24 h (in EH o n l y ) . 
The l a t t e r f i n d i n g i n the p a t i e n t s with EH i s compa-
t i b l e with the hypothesis that aldosterone i s an im-
portant f a c t o r i n the long-term c o n t r o l of k a l l i k r e i n 
formation (11). 
In conclusion, we found low k a l l i k r e i n e x c r e t i o n 
only i n a minority of p a t i e n t s with mild or moderate 
EH. Possibly,the reduced k a l l i k r e i n e x c r e t i o n found i n 
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a proportion of patients with EH i s secondary to the 
hypertensive process and not r e l a t e d to i t s o r i g i n . 
However, since r a c i a l d i fferences i n k a l l i k r e i n excre-
t i o n are known to e x i s t (9), low k a l l i k r e i n excretion 
could also be due to a genetic determinant. 
Thus, patients with low k a l l i k r e i n excretion might 
not represent a homogenous group, and at least i n some 
of the patients a genetic component might be responsible 
for the low k a l l i k r e i n e x c r e t i o n . 
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